Effects of non-catalytic, distal amino acid residues on activity of E. coli DinB (DNA polymerase IV)

Environmental and Molecular Mutagenesis

Volumn 53, Issue 9, 2012, Pages 766-776

  Walsh, Jason M ^a   Parasuram, Ramya ^a   Rajput, Pradyumna R ^a,c   Rozners, Eriks ^b   Ondrechen, Mary Jo ^a   Beuning, Penny J ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

^b BINGHAMTON UNIVERSITY   (United States)

^c IB Technology Solutions Inc   (United States)

Author keywords

Computational predictions of activity; Deoxyguanosine adduct; DNA damage; Homology model; Translesion synthesis

Indexed keywords

AMINO ACID; ARGININE; CYSTEINE; DINB PROTEIN; DNA POLYMERASE; ESCHERICHIA COLI PROTEIN; HISTIDINE; HYDROXYL GROUP; SERINE; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CONFORMATIONAL TRANSITION; DNA DAMAGE; DNA SYNTHESIS; ENZYME ACTIVITY; ESCHERICHIA COLI; MATHEMATICAL MODEL; MUTATION; NONHUMAN; PROTEIN STRUCTURE;

AMINO ACIDS; BASE SEQUENCE; CATALYTIC DOMAIN; DNA PRIMERS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; MODELS, MOLECULAR;

EID: 84868685608     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.21730     Document Type: Article

References (88)

1. Albertella MR, Green CM, Lehmann AR, O'Connor MJ. 2005. A role for polymerase eta in the cellular tolerance to cisplatin-induced damage. Cancer Res 65: 9799-9806.
2. Albertella MR, Lau A, O'Connor MJ. 2005a. The overexpression of specialized DNA polymerases in cancer. DNA Repair (Amst) 4: 583-593.
3. Alexander RW, Schimmel P. 2001. Domain-domain communication in aminoacyl-tRNA synthetases. Prog Nucleic Acid Res Mol Biol 69: 317-349.
4. Amasino R. 2005. 1955: Kinetin arrives: the 50th anniversary of a new plant hormone. Plant Physiol 138: 1177-1184.
5. Arnez JG, Moras D. 1997. Structural and functional considerations of the aminoacylation reaction. Trends Biochem Sci 22: 211-216.
6. Astatke M, Ng K, Grindley ND, Joyce CM. 1998. A single side chain prevents Escherichia coli DNA polymerase I (Klenow fragment) from incorporating ribonucleotides. Proc Natl Acad Sci U S A 95: 3402-3407.
7. Barciszewski J, Massino F, Clark BF. 2007. Kinetin--a multiactive molecule. Int J Biol Macromol 40: 182-192.
8. Barciszewski J, Mielcarek M, Stobiecki M, Siboska G, Clark BF. 2000. Identification of 6-furfuryladenine (kinetin) in human urine. Biochem Biophys Res Commun 279:69-73.
9. Barciszewski J, Siboska GE, Pedersen BO, Clark BF, Rattan SI. 1996. Evidence for the presence of kinetin in DNA and cell extracts. FEBS Lett 393: 197-200.
10. Bartlett GJ, Porter CT, Borkakoti N, Thornton JM. 2002. Analysis of catalytic residues in enzyme active sites. J Mol Biol 324: 105-121.
11. Bassett E, King NM, Bryant MF, Hector S, Pendyala L, Chaney SG, Cordeiro-Stone M. 2004. The role of DNA polymerase eta in translesion synthesis past platinum-DNA adducts in human fibroblasts. Cancer Res 64: 6469-6475.
12. Berdis AJ. 2009. Mechanisms of DNA polymerases. Chem Rev 109: 2862-2879.
13. Beuning PJ, Simon SM, Godoy VG, Jarosz DF, Walker GC. 2006. Characterization of Escherichia coli translesion synthesis polymerases and their accessory factors. Methods Enzymol 408: 318-340.
14. Biertumpfel C, Zhao Y, Kondo Y, Ramon-Maiques S, Gregory M, Lee JY, Masutani C, Lehmann AR, Hanaoka F, Yang W. 2010. Structure and mechanism of human DNA polymerase eta. Nature 465: 1044-1048.
15. Bonnin A, Lazaro JM, Blanco L, Salas M. 1999. A single tyrosine prevents insertion of ribonucleotides in the eukaryotic-type phi29 DNA polymerase. J Mol Biol 290: 241-251.
16. Bresson A, Fuchs RP. 2002. Lesion bypass in yeast cells: Pol eta participates in a multi-DNA polymerase process. EMBO J 21: 3881-3887.
17. Brodkin HR, Novak WR, Milne AC, D'Aquino JA, Karabacak NM, Goldberg IG, Agar JN, Payne MS, Petsko GA, Ondrechen MJ, Ringe D. 2011. Evidence of the participation of remote residues in the catalytic activity of co-type nitrile hydratase from Pseudomonas putida. Biochemistry 50: 4923-4935.
18. Broughton BC, Cordonnier A, Kleijer WJ, Jaspers NG, Fawcett H, Raams A, Garritsen VH, Stary A, Avril MF, Boudsocq F, Masutani C, Hanaoka F, Fuchs RP, Sarasin A, Lehmann AR. 2002. Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients. Proc Natl Acad Sci U S A 99: 815-820.
19. Brown JA, Suo Z. 2011. Unlocking the sugar"steric gate" of DNA polymerases. Biochemistry 50: 1135-1142.
20. Carpten JD, Faber AL, Horn C, Donoho GP, Briggs SL, Robbins CM, Hostetter G, Boguslawski S, Moses TY, Savage S, Uhlik M, Lin A, Du J, Qian YW, Zeckner DJ, Tucker-Kellogg G, Touchman J, Patel K, Mousses S, Bittner M, Schevitz R, Lai MH, Blanchard KL, Thomas JE. 2007. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 448: 439-444.
21. Chalissery J, Banerjee S, Bandey I, Sen R. 2007. Transcription termination defective mutants of Rho: Role of different functions of Rho in releasing RNA from the elongation complex. J Mol Biol 371: 855-872.
22. Chaptal V, Vincent F, Gueguen-Chaignon V, Monedero V, Poncet S, Deutscher J, Nessler S, Morera S. 2007. Structural analysis of the bacterial HPr kinase/phosphorylase V267F mutant gives insights into the allosteric regulation mechanism of this bifunctional enzyme. J Biol Chem 282: 34952-34957.
23. Chen YW, Cleaver JE, Hanaoka F, Chang CF, Chou KM. 2006. A novel role of DNA polymerase eta in modulating cellular sensitivity to chemotherapeutic agents. Mol Cancer Res 4: 257-265.
24. Cirz RT, Chin JK, Andes DR, de Crecy-Lagard V, Craig WA, Romesberg FE. 2005. Inhibition of mutation and combating the evolution of antibiotic resistance. PLoS Biol 3: e176.
25. Cirz RT, Jones MB, Gingles NA, Minogue TD, Jarrahi B, Peterson SN, Romesberg FE. 2007. Complete and SOS-mediated response of Staphylococcus aureus to the antibiotic ciprofloxacin. J Bacteriol 189: 531-539.
26. Cirz RT, O'Neill BM, Hammond JA, Head SR, Romesberg FE. 2006. Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacin. J Bacteriol 188: 7101-7110.
27. Cordonnier AM, Fuchs RP 1999. Replication of damaged DNA: Molecular defect in xeroderma pigmentosum variant cells. Mutat Res 435: 111-119.
28. Cusack S, Yaremchuk A, Tukalo M. 2000. The 2A crystal structure of leucyl-tRNA synthetase and its complex with a leucyl-adenylate analogue. EMBO J 19: 2351-2361.
29. 2 position of deoxyguanosine. Chem Res Toxicol 9: 630-637.
30. DeLucia AM, Grindley ND, Joyce CM. 2003. An error-prone family Y DNA polymerase (DinB homolog from Sulfolobus solfataricus) uses a 'steric gate' residue for discrimination against ribonucleotides. Nucleic Acids Res 31: 4129-4137.
31. Dupre ML, Broyles JM, Mihic SJ. 2007. Effects of a mutation in the TM2-TM3 linker region of the glycine receptor alpha1 subunit on gating and allosteric modulation. Brain Res 1152: 1-9.
32. El Omari K, Liekens S, Bird LE, Balzarini J, Stammers DK. 2006. Mutations distal to the substrate site can affect varicella zoster virus thymidine kinase activity: Implications for drug design. Mol Pharmacol 69: 1891-1896.
33. Fiala KA, Brown JA, Ling H, Kshetry AK, Zhang J, Taylor JS, Yang W, Suo Z. 2007. Mechanism of template-independent nucleotide incorporation catalyzed by a template-dependent DNA polymerase. J Mol Biol 365: 590-602.
34. Friedberg EC, Walker GC, Siede WW, Wood RD, Schultz RA, Ellenberger T. 2006. DNA repair and mutagenesis, 2nd edition. Washington, D.C.: ASM Press. 1118 p.
35. Friedberg EC. 2005. Suffering in silence: The tolerance of DNA damage. Nat Rev Mol Cell Biol 6: 943-953.
36. Friedberg EC, Wagner R, Radman M. 2002. Specialized DNA polymerases, cellular survival, and the genesis of mutations. Science 296: 1627-1630.
37. Fujii S, Fuchs RP. 2004. Defining the position of the switches between replicative and bypass DNA polymerases. EMBO J 23: 4342-4352.
38. Glaser F, Pupko T, Paz I, Bell RE, Bechor-Shental D, Martz E, Ben-Tal N. 2003. ConSurf: Identification of functional regions in proteins by surface-mapping of phylogenetic information. Bioinformatics 19: 163-164.
39. Goodman MF. 2002. Error-prone repair DNA polymerases in prokaryotes and eukaryotes. Annu Rev Biochem 71: 17-50.
40. Heitman LH, Mulder-Krieger T, Spanjersberg RF, von Frijtag Drabbe Kunzel JK, Dalpiaz A, Ijzerman AP. 2006. Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A1 receptors of LUF5831, a novel nonadenosine-like agonist. Br J Pharmacol 147: 533-541.
41. Ho TV, Guainazzi A, Derkunt SB, Enoiu M, Scharer OD. 2011. Structure-dependent bypass of DNA interstrand crosslinks by translesion synthesis polymerases. Nucleic Acids Res 39: 7455-7464.
42. Hong BS, Senisterra G, Rabeh WM, Vedadi M, Leonardi R, Zhang YM, Rock CO, Jackowski S, Park HW. 2007. Crystal structures of human pantothenate kinases. Insights into allosteric regulation and mutations linked to a neurodegeneration disorder. J Biol Chem 282: 27984-27993.
43. Ignatov KB, Bashirova AA, Miroshnikov AI, Kramarov VM. 1999. Mutation S543N in the thumb subdomain of the Taq DNA polymerase large fragment suppresses pausing associated with the template structure. FEBS Lett 448: 145-148.
44. Inui H, Oh KS, Nadem C, Ueda T, Khan SG, Metin A, Gozukara E, Emmert S, Slor H, Busch DB, Baker CC, DiGiovanna JJ, Tamura D, Seitz CS, Gratchev A, Wu WH, Chung KY, Chung HJ, Azizi E, Woodgate R, Schneider TD, Kraemer KH. 2008. Xeroderma pigmentosum-variant patients from America, Europe, and Asia. J Invest Dermatol 128: 2055-2068.
45. Itoh T, Linn S, Kamide R, Tokushige H, Katori N, Hosaka Y, Yamaizumi M. 2000. Xeroderma pigmentosum variant heterozygotes show reduced levels of recovery of replicative DNA synthesis in the presence of caffeine after ultraviolet irradiation. J Invest Dermatol 115: 981-985.
46. Jarosz DF, Cohen SE, Delaney JC, Essigmann JM, Walker GC. 2009. A DinB variant reveals diverse physiological consequences of incomplete TLS extension by a Y-family DNA polymerase. Proc Natl Acad Sci U S A 106: 21137-21142.
47. Jarosz DF, Godoy VG, Delaney JC, Essigmann JM, Walker GC. 2006. A single amino acid governs enhanced activity of DinB DNA polymerases on damaged templates. Nature 439: 225-228.
48. Johnson RE, Kondratick CM, Prakash S, Prakash L. 1999. hRAD30 mutations in the variant form of xeroderma pigmentosum. Science 285: 263-265.
49. Klyuyeva A, Tuganova A, Popov KM. 2008. Allosteric coupling in pyruvate dehydrogenase kinase 2. Biochemistry 47: 8358-8366.
50. Ko J, Murga LF, Andre P, Yang H, Ondrechen MJ, Williams RJ, Agunwamba A, Budil DE. 2005. Statistical criteria for the identification of protein active sites using theoretical microscopic titration curves. Proteins 59: 183-195.
51. Kraemer KH, Slor H. 1985. Xeroderma pigmentosum. Clin Dermatol 3: 33-69.
52. Krieger E, Koraimann G, Vriend G. 2002. Increasing the precision of comparative models with YASARA NOVA-A self-parameterizing force field. Proteins 47: 393-402.
53. Lange SS, Takata K, Wood RD. 2011. DNA polymerases and cancer. Nat Rev Cancer 11: 96-110.
54. Lee J, Goodey NM. 2011. Catalytic contributions from remote regions of enzyme structure. Chem Rev 111: 7595-7624.
55. Ling H, Boudsocq F, Woodgate R, Yang W. 2001. Crystal structure of a Y-family DNA polymerase in action: A mechanism for error-prone and lesion-bypass replication. Cell 107: 91-102.
56. Loeb LA, Monnat RJJr. 2008. DNA polymerases and human disease. Nat Rev Genet 9: 594-604.
57. Lovell SC, Davis IW, Arendall WB, 3rd, de Bakker PI, Word JM, Prisant MG, Richardson JS, Richardson DC. 2003. Structure validation by Calpha geometry: phi, psi and Cbeta deviation. Proteins 50: 437-450.
58. Lue SW, Kelley SO. 2007. A single residue in leucyl-tRNA synthetase affecting amino acid specificity and tRNA aminoacylation. Biochemistry 46: 4466-4472.
59. Masutani C, Kusumoto R, Yamada A, Dohmae N, Yokoi M, Yuasa M, Araki M, Iwai S, Takio K, Hanaoka F. 1999. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature 399: 700-704.
60. Miller C, Thomsen LE, Gaggero C, Mosseri R, Ingmer H, Cohen SN. 2004. SOS response induction by beta-lactams and bacterial defense against antibiotic lethality. Science 305: 1629-1631.
61. Mirza M, Robinson P, Kremneva E, Copeland O, Nikolaeva O, Watkins H, Levitsky D, Redwood C, El-Mezgueldi M, Marston S. 2007. The effect of mutations in alpha-tropomyosin (E40K and E54K) that cause familial dilated cardiomyopathy on the regulatory mechanism of cardiac muscle thin filaments. J Biol Chem 282: 13487-13497.
62. Murphy DL, Jaeger J, Sweasy JB. 2011. A triad interaction in the fingers subdomain of DNA polymerase beta controls polymerase activity. J Am Chem Soc 133: 6279-6287.
63. Napolitano R, Janel-Bintz R, Wagner J, Fuchs RP. 2000. All three SOS-inducible DNA polymerases (Pol II, Pol IV and Pol V) are involved in induced mutagenesis. EMBO J 19: 6259-6265.
64. Ogawa M, Tosaka A, Ito Y, Yoshida S, Suzuki M. 2001. Enhanced ribonucleotide incorporation by an O-helix mutant of Thermus aquaticus DNA polymerase I. Mutat Res 485: 197-207.
65. Ondrechen MJ, Clifton JG, Ringe D. 2001. THEMATICS: A simple computational predictor of enzyme function from structure. Proc Natl Acad Sci U S A 98: 12473-12478.
66. Pages V, Fuchs RP. 2002. How DNA lesions are turned into mutations within cells? Oncogene 21: 8957-8966.
67. Patel PH, Loeb LA. 2000. Multiple amino acid substitutions allow DNA polymerases to synthesize RNA. J Biol Chem 275: 40266-40272.
68. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. 2004. UCSF Chimera-A visualization system for exploratory research and analysis. J Comput Chem 25: 1605-1612.
69. Porter CT, Bartlett GJ, Thornton JM. 2004. The Catalytic Site Atlas: A resource of catalytic sites and residues identified in enzymes using structural data. Nucleic Acids Res 32: D129-133.
70. Prakash S, Johnson RE, Prakash L. 2005. Eukaryotic translesion synthesis DNA polymerases: Specificity of structure and function. Annu Rev Biochem 74: 317-353.
71. Sankararaman S, Kolaczkowski B, Sjölander K. 2009. INTREPID: A web server for prediction of functionally important residues by evolutionary analysis. Nucleic Acids Research 37: W390-W395.
72. Segel I. 1993. Enzyme Kinetics: Behavior and analysis of rapid equilibrium and steady-state enzyme systems. New York, NY: Wiley-Interscience.
73. Shen X, Sayer JM, Kroth H, Ponten I, O'Donnell M, Woodgate R, Jerina DM, Goodman MF. 2002. Efficiency and accuracy of SOS-induced DNA polymerases replicating benzo[a]pyrene-7, 8-diol 9, 10-epoxide A and G adducts. J Biol Chem 277: 5265-5274.
74. Sherrer SM, Beyer DC, Xia CX, Fowler JD, Suo Z. 2010. Kinetic basis of sugar selection by a Y-family DNA polymerase from Sulfolobus solfataricus P2. Biochemistry 49: 10179-10186.
75. Shurtleff BW, Ollivierre JN, Tehrani M, Walker GC, Beuning PJ 2009. Steric gate variants of UmuC confer UV hypersensitivity on Escherichia coli. J Bacteriol 191: 4815-4823.
76. Somarowthu S, Brodkin HR, D'Aquino JA, Ringe D, Ondrechen MJ, Beuning PJ. 2011a. A tale of two isomerases: Compact versus extended active sites in ketosteroid isomerase and phosphoglucose isomerase. Biochemistry 50: 9283-9295.
77. Somarowthu S, Yang H, Hildebrand DG, Ondrechen MJ. 2011b. High-performance prediction of functional residues in proteins with machine learning and computed input features. Biopolymers 95: 390-400.
78. Suzuki M, Yoshida S, Adman ET, Blank A, Loeb LA. 2000. Thermus aquaticus DNA polymerase I mutants with altered fidelity. Interacting mutations in the O-helix. J Biol Chem 275: 32728-32735.
79. Tanioka M, Masaki T, Ono R, Nagano T, Otoshi-Honda E, Matsumura Y, Takigawa M, Inui H, Miyachi Y, Moriwaki S, Nishigori C. 2007. Molecular analysis of DNA polymerase eta gene in Japanese patients diagnosed as xeroderma pigmentosum variant type. J Invest Dermatol 127: 1745-1751.
80. Tong W, Wei Y, Murga LF, Ondrechen MJ, Williams RJ. 2009. Partial order optimum likelihood (POOL): Maximum likelihood prediction of protein active site residues using 3D Structure and sequence properties. PLoS Comput Biol 5: e1000266.
81. Wagner J, Gruz P, Kim SR, Yamada M, Matsui K, Fuchs RP, Nohmi T. 1999. The dinB gene encodes a novel E. coli DNA polymerase, DNA pol IV, involved in mutagenesis. Mol Cell 4: 281-286.
82. Walsh JM, Bouamaied I, Brown T, Wilhelmsson LM, Beuning PJ. 2011a. Discrimination against the cytosine analog tC by Escherichia coli DNA polymerase IV DinB. J Mol Biol 409: 89-100.
83. Walsh JM, Hawver LA, Beuning PJ. 2011b. Escherichia coli Y family DNA polymerases. Front Biosci 17: 3164-3182.
84. Wei Y, Ko J, Murga L, Ondrechen MJ. 2007. Selective prediction of interaction sites in protein structures with THEMATICS. BMC Bioinformatics 8: 119.
85. Weimer KM, Shane BL, Brunetto M, Bhattacharyya S, Hati S. 2009. Evolutionary basis for the coupled-domain motions in Thermus thermophilus leucyl-tRNA synthetase. J Biol Chem 284: 10088-10099.
86. Yamtich J, Sweasy JB. 2010. DNA polymerase family X: function, structure, and cellular roles. Biochim Biophys Acta 1804: 1136-1150.
87. Yang G, Franklin M, Li J, Lin TC, Konigsberg W. 2002. A conserved Tyr residue is required for sugar selectivity in a Pol alpha DNA polymerase. Biochemistry 41: 10256-10261.
88. 2-(1-carboxyethyl)-2'-deoxyguanosine by DinB DNA polymerase in vitro and in vivo. Proc Natl Acad Sci U S A 105: 8679-8684.